Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Ironman finisher Stacy Ahearn on getting back in shape after a rare disease diagnosis.
We asked patients for advice on managing their rare disease while traveling.
One mom’s advice for launching a successful fundraising campaign.
Watch: Jesse Schrader’s tips for staying active with a bleeding disorder.
Former pitcher and hemophilia patient Jesse Schrader on managing health.
From rock to hip-hop to show tunes, all genres make the playlist.
Clean hands can prevent the spread of illness – critical for those with chronic conditions
Which films get it right? We asked real patients and “The Big Sick” made the cut.
Americas
Asia Pacific
Middle East
Europe
